Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

Shire building

Shire in $300m Foresight acquisition

August 4, 2015 Manufacturing and Production, Research and Development, Sales and Marketing FST-100, Foresight Biotherapeutics, Shire, conjunctivitis, dry eye, lifitegrast, pink eye

Shire has acquired Foresight Biotherapeutics for $300 million, as it looks to build its presence in eye diseases. The acquisition …
News

CSL completes $275m Novartis vaccines acquisition

August 3, 2015 Manufacturing and Production, Sales and Marketing CSL, Novartis, acquisitions, asset swap, vaccines

CSL Limited has finalised its transaction to acquire Novartis’s global influenza vaccine business for $275 million. The move means Novartis …
News
Lee Heeson

Working Life: Celgene’s Lee Heeson

August 3, 2015 Medical Communications, Sales and Marketing Celgene, Lee Heeson

How did you find your way into your current role?My career has progressed from ‘carrying the bag’ for GlaxoSmithKline in …
Feature
Roche building

Eleven companies accused in Romanian corruption probe

August 3, 2015 Business Services, Medical Communications, Sales and Marketing China, Daily Telegraph, GSK, Roche, Romania, bribery, corruption

GSK and Roche are among eleven pharma firms being investigated for paying bribes to doctors in Romania to prescribe drugs. …
News
Humira

AbbVie’s Humira receives first European OK for skin condition

August 3, 2015 Sales and Marketing AbbVie, Hidradenitis suppurativa, Humira, adalimumab

The European Commission has approved AbbVie’s Humira as a treatment for moderate-to-severe hidradenitis suppurativa – a chronic condition affecting the …
News
WHO flag

Encouraging first results from trial of Merck’s Ebola vaccine

July 31, 2015 Research and Development, Sales and Marketing Africa, EBV, Ebola, Ebola virus, Ebola virus disease, Vaccine, WHO, World Health Organisation, guinea, vaccination

The first trial of an experimental Ebola vaccine suggests it provides high protection against the disease as early as ten …
News
ABPI sign

ABPI consulting on Code of Conduct changes

July 31, 2015 Medical Communications, Sales and Marketing ABPI Code, PMCPA, Prescription Medicines Code of Practice Authority, code of conduct

The division of the ABPI that sets rules governing industry behaviour is consulting on changes to reflect new rules on …
News
depomedlogo

Depomed rejects Horizon’s latest takeover bid

July 30, 2015 Sales and Marketing Depomed, horizon, mergers and acquisitions, takeovers

Depomed has rejected Horizon Pharma’s latest bid, stating the proposal is ‘inadequate’ and ’undervalues’ the company. The Irish pharma company …
News
Aubiago

Sanofi sales boosted by rare disease and multiple sclerosis drugs

July 30, 2015 Manufacturing and Production, Sales and Marketing Genzyme, Oliver Brandicourt, Sanofi, brandicourt, financial results

Sales at pharma giant Sanofi increased by 5% in the second quarter of 2016 to nearly €10 billion, its latest …
News
Daklinza

NICE restricts access to new hepatitis C treatments

July 29, 2015 Sales and Marketing AbbVie, BMS, Bristol-Myers Squibb, Exviera, Gilead, NICE, daklinza, harvoni, hepatits C

NICE has recommended three new treatment options for hepatitis C in draft guidance – but has been criticised for excluding …
News
Takeda oncology

Takeda cancer drug gets EMA boost

July 29, 2015 Research and Development, Sales and Marketing Takeda, ixazomib, multiple myeloma

The EMA has granted Takeda an accelerated assessment for its multiple myeloma drug, ixazomib. The Agency’s Committee for Medicinal Products …
News

David Khougazian announced as president of Sanofi Pasteur MSD

July 29, 2015 Business Services, Research and Development, Sales and Marketing MSD, Merck, Sanofi Pasteur

Sanofi Pasteur and Merck have appointed David Khougazian as president of their joint company, Sanofi Pasteur MSD. David Khougazian joined …
Appointment
dr_james_shannon

Dr James Shannon joins Immodulon Therapeutics board of directors

July 29, 2015 Research and Development, Sales and Marketing Immodulon

Dr James Shannon has joined Immodulon as a non-executive director with immediate effect. Bringing with him 30 years’ of experience …
Appointment
Antibiotic resistance

Rising to meet the infectious disease challenge

July 27, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Antibiotics, R&D, antibiotic resistance, infectious disease

Antibiotic-resistant infections gather more headlines than most other infectious disease topics, and have typically been seen as a neglected area …
Feature
Sanofi Regeneron

FDA and EMA approve heart drug Praluent

July 27, 2015 Sales and Marketing EMA, FDA, PCSK9, Regeneron, Sanofi, high cholesterol, praluent

The FDA and the EMA have both approved Sanofi and Regeneron’s new high cholesterol drug Praluent. Regulators on both sides …
News
The Gateway to Local Adoption Series

Latest content

China approves fruquintinib combination for kidney cancer

May 29, 2026

BIOTRONIK, Charité and GHCF launch digital cardiology partnership

May 28, 2026

Endometriosis study begins recruitment in UK hospitals

May 28, 2026

MHRA authorises donidalorsen for hereditary angioedema prevention

May 27, 2026

Partnership aims to expand early access to medicines

May 26, 2026